Literature DB >> 20145341

Association of the functional variant in the 3-hydroxy-3-methylglutaryl-coenzyme a reductase gene with low-density lipoprotein-cholesterol in Japanese.

Yumiko Hiura1, Yasuharu Tabara, Yoshihiro Kokubo, Tomonori Okamura, Yoichi Goto, Hiroshi Nonogi, Tetsuro Miki, Hitonobu Tomoike, Naoharu Iwai.   

Abstract

BACKGROUND: The association between single nucleotide polymorphisms (SNPs) at 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) and low-density lipoprotein-cholesterol (LDL-C) levels has been well replicated in genome-wide association studies (GWAS) of white populations. Recently, the common intronic SNP of HMGCR (rs3846662) has been reported to be a functional variant, influencing the alternative splicing of exon 13. The aim of this study was to examine the association between rs3846662 of HMGCR and the level of LDL-C in Japanese. METHODS AND
RESULTS: Significant differences in LDL-C levels were observed among the genotypes of rs3846662 (P=0.0002 (n=2,686) and P=0.004 (n=2,110)) for the Suita and Ehime samples, respectively. The G allele of rs3846662 was associated with higher LDL-C levels (beta, 3.56; P=4.91x10(-5)). Consistent with this observation, the risk G allele at rs3846662 was more prevalent in subjects with myocardial infarction (MI) (n=701) than in subjects without MI (n=3,118); 0.559 and 0.511 in MI cases and controls, respectively (nominal P=0.0038). The odds ratio adjusted for age, sex, diabetes, hypertension, and drinking and smoking habits was 1.15 (95% confidence interval 1.04-1.28; P=0.0075).
CONCLUSIONS: The previously reported association of rs3846662 with LDL-C levels was replicated in the present Suita and Ehime samples. The LDL-associated SNP, rs3846662, appears to confer susceptibility to MI in Japanese.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20145341     DOI: 10.1253/circj.cj-09-0790

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  8 in total

Review 1.  Low-density lipoprotein cholesterol, apolipoprotein B, and risk of coronary heart disease: from familial hyperlipidemia to genomics.

Authors:  Christopher C Imes; Melissa A Austin
Journal:  Biol Res Nurs       Date:  2012-04-23       Impact factor: 2.522

2.  Role of rs3846662 and HMGCR alternative splicing in statin efficacy and baseline lipid levels in familial hypercholesterolemia.

Authors:  Valerie Leduc; Lucienne Bourque; Judes Poirier; Robert Dufour
Journal:  Pharmacogenet Genomics       Date:  2016-01       Impact factor: 2.089

Review 3.  Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk.

Authors:  Sebastiano Calandra; Patrizia Tarugi; Helen E Speedy; Andrew F Dean; Stefano Bertolini; Carol C Shoulders
Journal:  J Lipid Res       Date:  2011-08-23       Impact factor: 5.922

4.  Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.

Authors:  Lei Cao; Hui-Fu Wang; Lin Tan; Fu-Rong Sun; Meng-Shan Tan; Chen-Chen Tan; Teng Jiang; Jin-Tai Yu; Lan Tan
Journal:  Oncotarget       Date:  2016-03-22

5.  Effects of rs3846662 Variants on HMGCR mRNA and Protein Levels and on Markers of Alzheimer's Disease Pathology.

Authors:  Valerie Leduc; Louise Théroux; Doris Dea; Robert Dufour; Judes Poirier
Journal:  J Mol Neurosci       Date:  2015-11-05       Impact factor: 3.444

6.  Evaluation of the global association between cholesterol-associated polymorphisms and Alzheimer's disease suggests a role for rs3846662 and HMGCR splicing in disease risk.

Authors:  Christopher R Simmons; Fanggeng Zou; Steven G Younkin; Steven Estus
Journal:  Mol Neurodegener       Date:  2011-08-25       Impact factor: 14.195

7.  Genetic Contribution of Variants near SORT1 and APOE on LDL Cholesterol Independent of Obesity in Children.

Authors:  Clara Breitling; Arnd Gross; Petra Büttner; Sebastian Weise; Dorit Schleinitz; Wieland Kiess; Markus Scholz; Peter Kovacs; Antje Körner
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

8.  Relationship between Lipid Phenotypes, Overweight, Lipid Lowering Drug Response and KIF6 and HMG-CoA Genotypes in a Subset of the Brisighella Heart Study Population.

Authors:  Sabrina Angelini; Martina Rosticci; Gianmichele Massimo; Muriel Musti; Gloria Ravegnini; Nicola Consolini; Giulia Sammarini; Sergio D'Addato; Elisabetta Rizzoli; Dauren Botbayev; Claudio Borghi; Giorgio Cantelli-Forti; Arrigo F Cicero; Patrizia Hrelia
Journal:  Int J Mol Sci       Date:  2017-12-24       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.